Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma

Summary

The purpose of this research is to help researchers find out if SP-3164 is safe and if it may be of benefit in the treatment of patients with Non-Hodgkin's lymphoma that has progressed after prior treatment, or that never responded to previous treatment.

Timeline

Start

2024-03-15

Primary completion

2025-08-15

Completion

2027-08-15

Drugs

Indications